July 11, 2025
Leverage two decades of nasal experience and world-class aseptic manufacturing to progress your preservative-free nasal spray to patients.
READ MORE READ MORE
April 24, 2025
Nasal spray repositioning through the 505(b)(2) regulatory pathway has emerged as a compelling approach, offering a unique opportunity to breathe new life into existing drugs and improve patient experiences.
READ MORE READ MORE
December 9, 2024
Throughout your nasal spray development journey, you are likely to face pressure to accelerate timelines to clinical phases, stemming from the need to:
READ MORE READ MORE
April 24, 2024
Rohit Mulik, Senior Manager: Formulation R&D, and Eric Kaneps, VP, Sales & Marketing at Renaissance Lakewood LLC, answer questions about the challenges in nasal drug delivery and outline how CDMO partnerships can help to overcome them.
READ MORE READ MORE
Supporting nasal product R&D and clinical manufacturing at Renaissance Learn more about the Nasal Product space and how Renaissance is making an impact.
READ MORE READ MORE
October 19, 2022
Overview: The following case study is a collaboration with Renaissance Lakewood and Raven consulting on continuous...
READ MORE READ MORE
October 6, 2022
A look at the interconnected role of the formulation, formulation excipients, and nasal spray...
READ MORE READ MORE
September 20, 2022
A review of nasal spray formulation excipients and their potential for enhancing drug delivery. Test
READ MORE READ MORE
August 22, 2022
When developing a sterile product, people often do not understand what’s required to manufacture the product....
READ MORE READ MORE
August 1, 2022
A CDMO is a Contract Development and Manufacturing Organization that accelerates how pharmaceutical companies bring drugs and therapies to market. The drug discovery to market pipeline is filled with many challenges, partnering with a CDMO lowers the risk and capital investment associated with this multi-step, multi-year, and often multi-million-dollar process.
READ MORE READ MORE"*" indicates required fields